首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
EU POLICY ON ORPHAN DRUGS
被引:1
|
作者
:
LEWIS, S
论文数:
0
引用数:
0
h-index:
0
LEWIS, S
机构
:
来源
:
LANCET
|
1995年
/ 345卷
/ 8963期
关键词
:
D O I
:
10.1016/S0140-6736(95)91053-0
中图分类号
:
R5 [内科学];
学科分类号
:
1002 ;
100201 ;
摘要
:
引用
收藏
页码:1500 / 1500
页数:1
相关论文
共 50 条
[21]
ORPHAN DRUGS
BLANCHARD, T
论文数:
0
引用数:
0
h-index:
0
BLANCHARD, T
NATURE,
1992,
358
(6387)
: 534
-
534
[22]
Orphan drugs
Messori, Andrea
论文数:
0
引用数:
0
h-index:
0
机构:
Reg Hlth Serv, Sect Pharmaceut, I-50135 Florence, Regione Toscana, Italy
Reg Hlth Serv, Sect Pharmaceut, I-50135 Florence, Regione Toscana, Italy
Messori, Andrea
Attanasio, Francesco
论文数:
0
引用数:
0
h-index:
0
机构:
Reg Hlth Serv, Sect Pharmaceut, I-50135 Florence, Regione Toscana, Italy
Reg Hlth Serv, Sect Pharmaceut, I-50135 Florence, Regione Toscana, Italy
Attanasio, Francesco
Trippoli, Sabrina
论文数:
0
引用数:
0
h-index:
0
机构:
Reg Hlth Serv, Sect Pharmaceut, I-50135 Florence, Regione Toscana, Italy
Reg Hlth Serv, Sect Pharmaceut, I-50135 Florence, Regione Toscana, Italy
Trippoli, Sabrina
Banfi, Roberto
论文数:
0
引用数:
0
h-index:
0
机构:
Reg Hlth Serv, Sect Pharmaceut, I-50135 Florence, Regione Toscana, Italy
Reg Hlth Serv, Sect Pharmaceut, I-50135 Florence, Regione Toscana, Italy
Banfi, Roberto
LANCET,
2019,
393
(10181):
: 1595
-
1595
[23]
Orphan drugs
Burke, Maria
论文数:
0
引用数:
0
h-index:
0
Burke, Maria
CHEMISTRY & INDUSTRY,
2013,
77
(09)
: 38
-
41
[24]
TIME TO REIMBURSEMENT FOR ORPHAN DRUGS IN EU5 IN THE LAST FIVE YEARS
Molchanova, E.
论文数:
0
引用数:
0
h-index:
0
机构:
Intexo Societa Benefit, Rome, RM, Italy
Intexo Societa Benefit, Rome, RM, Italy
Molchanova, E.
Benazet, F.
论文数:
0
引用数:
0
h-index:
0
机构:
Nextep, Paris 75, France
MEDVANCE France, Paris 75, France
Intexo Societa Benefit, Rome, RM, Italy
Benazet, F.
Vollmer, L.
论文数:
0
引用数:
0
h-index:
0
机构:
MArS Market Access & Pricing Strategy GmbH, Tubingen, BW, Germany
MEDVANCE Germany, Tubingen, BW, Germany
Intexo Societa Benefit, Rome, RM, Italy
Vollmer, L.
Pomares, E.
论文数:
0
引用数:
0
h-index:
0
机构:
Oblikue Consulting, Barcelona B, Spain
MEDVANCE Spain, Barcelona B, Spain
Intexo Societa Benefit, Rome, RM, Italy
Pomares, E.
Danev, V
论文数:
0
引用数:
0
h-index:
0
机构:
Remap Consulting, Rainow, Che, England
Intexo Societa Benefit, Rome, RM, Italy
Danev, V
Prada, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Intexo Societa Benefit, Rome, RM, Italy
Intexo Societa Benefit, Rome, RM, Italy
Prada, M.
VALUE IN HEALTH,
2020,
23
: S701
-
S701
[25]
Orphan Drugs
Schaefer, Juergen R.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Klinikum Giessen & Marburg, ZusE, Baldingerstr 1, D-35033 Marburg, Germany
Univ Klinikum Giessen & Marburg, ZusE, Baldingerstr 1, D-35033 Marburg, Germany
Schaefer, Juergen R.
Vogelmeier, Claus F.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Klinikum Giessen & Marburg, Klin Innere Med Pneumol Intens & Schlafmed, Baldingerstr 1, D-35033 Marburg, Germany
Univ Klinikum Giessen & Marburg, ZusE, Baldingerstr 1, D-35033 Marburg, Germany
Vogelmeier, Claus F.
INTERNIST,
2019,
60
(04):
: 396
-
398
[26]
ORPHAN DRUGS
SCHIFFRIN, MJ
论文数:
0
引用数:
0
h-index:
0
SCHIFFRIN, MJ
ANNALS OF ALLERGY,
1982,
48
(01):
: 63
-
65
[27]
ORPHAN DRUGS
RHEIN, R
论文数:
0
引用数:
0
h-index:
0
RHEIN, R
BRITISH MEDICAL JOURNAL,
1992,
304
(6825):
: 465
-
465
[28]
COMPARISON OF EARLY ACCESS PROGRAMMES FOR ORPHAN DRUGS IN THE EU-5 COUNTRIES
Schleich, W.
论文数:
0
引用数:
0
h-index:
0
机构:
MArS Market Access & Pricing Strategy GmbH & MEDV, Weil Am Rhein, Germany
MArS Market Access & Pricing Strategy GmbH & MEDV, Weil Am Rhein, Germany
Schleich, W.
Vollmer, L.
论文数:
0
引用数:
0
h-index:
0
机构:
MArS Market Access & Pricing Strategy GmbH & MEDV, Tubingen, Germany
MArS Market Access & Pricing Strategy GmbH & MEDV, Weil Am Rhein, Germany
Vollmer, L.
Prada, M.
论文数:
0
引用数:
0
h-index:
0
机构:
INTEXO Srl, Rome, Italy
MArS Market Access & Pricing Strategy GmbH & MEDV, Weil Am Rhein, Germany
Prada, M.
Berard, I
论文数:
0
引用数:
0
h-index:
0
机构:
Nextep & MEDVANCE France, Paris 75, France
MArS Market Access & Pricing Strategy GmbH & MEDV, Weil Am Rhein, Germany
Berard, I
Benazet, F.
论文数:
0
引用数:
0
h-index:
0
机构:
Nextep & MEDVANCE France, Paris 75, France
MArS Market Access & Pricing Strategy GmbH & MEDV, Weil Am Rhein, Germany
Benazet, F.
Brosa, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Oblikue Consulting & MEDVANCE Spain, Barcelona, Spain
MArS Market Access & Pricing Strategy GmbH & MEDV, Weil Am Rhein, Germany
Brosa, M.
Forsyth, C.
论文数:
0
引用数:
0
h-index:
0
机构:
Decideum & MEDVANCE UK, London, England
MArS Market Access & Pricing Strategy GmbH & MEDV, Weil Am Rhein, Germany
Forsyth, C.
VALUE IN HEALTH,
2019,
22
: S855
-
S856
[29]
THE ORPHAN DRUGS
KASILO, O
论文数:
0
引用数:
0
h-index:
0
KASILO, O
FIORICA, E
论文数:
0
引用数:
0
h-index:
0
FIORICA, E
REGGI, V
论文数:
0
引用数:
0
h-index:
0
REGGI, V
TOGNONI, G
论文数:
0
引用数:
0
h-index:
0
TOGNONI, G
MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA,
1986,
6
(03):
: 295
-
300
[30]
ORPHAN DRUGS
RHEIN, R
论文数:
0
引用数:
0
h-index:
0
RHEIN, R
BRITISH MEDICAL JOURNAL,
1990,
301
(6745):
: 198
-
199
←
1
2
3
4
5
→